Moreover, like the endogenous AhR agonists, they may also reduce the Aβ load in APP/PS1 mice and mild cognitive impairment patients through active AhR and alter the expression and activity of matrix metalloproteinases 47, 48. Here, APP is linked to Cognitive impairment.